Can Progesterone Cause Rash on Chest?
Yes, progesterone can cause a rash on the chest, though this is an uncommon adverse reaction. This can occur through a rare condition called autoimmune progesterone dermatitis (APD), which represents a delayed hypersensitivity reaction to progesterone.
Evidence from FDA Drug Labeling
The FDA-approved progesterone drug label explicitly lists skin reactions among reported adverse effects 1. Specifically documented reactions include:
- Pruritus (itching)
- Urticaria (hives)
- Alopecia
Postmarketing surveillance has identified additional dermatologic reactions including hypersensitivity reactions and anaphylactic reactions 1. The drug label notes that "Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate the frequency or establish a causal relationship to drug exposure" 1.
Autoimmune Progesterone Dermatitis: A Rare but Real Entity
Autoimmune progesterone dermatitis is a documented delayed hypersensitivity reaction that can manifest as rashes on the chest and other body areas. Research evidence confirms this phenomenon:
A 2019 case report documented a pregnant woman who developed "pruritic pustules, blisters, and crusts across her chest, back and extremities" 23 days after initiating vaginal progesterone 2. The lesions resolved after discontinuing progesterone.
Another case described "painful, erythematous, patchy skin lesions on face and chest" that were cyclically related to progesterone exposure 3. The diagnosis was confirmed through vaginal progesterone provocation testing.
A 2022 case report documented a patient with "a rash with severe pruritus" that was confirmed as APD through positive progesterone intradermal testing 4.
Clinical Presentation Patterns
The rash associated with progesterone hypersensitivity can present in various forms:
- Urticarial lesions (hives)
- Eczematous eruptions 5
- Pustules and blisters 2
- Erythematous patches 3
- Pemphigoid-like presentations 5
The chest is a commonly affected area, along with the face, back, and extremities 2, 3.
Common Pitfalls and Diagnostic Considerations
The key diagnostic challenge is recognizing APD, as it can mimic other dermatologic conditions. Clinicians should consider:
- Temporal relationship: Does the rash correlate with progesterone administration or menstrual cycle phases?
- Resolution pattern: Does the rash improve when progesterone is discontinued? 2
- Differential diagnosis: Rule out acne vulgaris, psoriasis, atopic dermatitis, lichen planus, and infections 3
Management Approach
If progesterone-induced rash is suspected, the primary intervention is discontinuation of progesterone 2. The FDA drug label recommends:
- Patients should report any unusual symptoms to their healthcare provider immediately 1
- Allergic reactions warrant drug discontinuation
- Patients with known hypersensitivity should not use progesterone products 1
For confirmed APD cases, treatment options documented in the literature include:
Context from Hormone Therapy Guidelines
While guidelines on menopausal hormone therapy discuss various side effects of progestational compounds—including mood swings, bloating, fluid retention, and sleep disturbance 6—dermatologic reactions are not prominently featured in these guidelines. This reflects the rarity of these reactions rather than their non-existence.
The guidelines note that "side effects of progestational compounds are difficult to evaluate and vary with the progestational agent administered" 6, and recommend switching among various progestational agents if side effects occur 6.
Bottom Line for Clinical Practice
Progesterone can cause chest rash, but this is uncommon. When it occurs, consider autoimmune progesterone dermatitis, particularly if the rash is pruritic, cyclical, or temporally related to progesterone administration. Discontinue progesterone if hypersensitivity is suspected, and consider alternative hormonal strategies if progesterone therapy is medically necessary.